成人欧美一区二区三区,天天干天天操天天爱,免费特黄一级欧美大片在线看 ,亚洲中文字幕无码一区日日添

    <span id="alen4"></span>

    <li id="alen4"></li>

      Recombinant Viral MIP-2

      更多活動(dòng)更多優(yōu)惠,盡在翌圣商城》

      批量采購, 請點(diǎn)擊詢價(jià)

      產(chǎn)品說明書

      FAQ

      COA

      已發(fā)表文獻(xiàn)

      Viral MIP-2 is one of the three chemokine-like proteins expressed by the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus, KSHV) and the other is ViMIP-1 and ViMIP-3. Viral MIP-II cDNA encodes a 94 amino acid (aa) residue precursor protein with a 23 aa residue signal peptide that is cleaved to yield a 71 aa residue mature protein. It shares 41 % and 48 % with human MIP-1α and ViMIP-1, respectively. ViMIP-2 has been shown to have antagonist activity towards a wide range of chemokine receptors and has functions of blocking infection by several different human immunodeficiency virus type 1 (HIV-1) strains. It may form part of the response to host defenses contributing to virus-induced neoplasia and may have relevance to KSHV and HIV-I interactions. Additionally, ViMIP-2 has been shown to activate and chemoattract human eosinphils.

       

      Product Properties

      Synonyms

      Viral Macrophage Inflammatory Protein II, vMIP-1B, MIP-II, vMIP-2

      Accession

      Q98157

      GeneID

      4961514

      Source

      E.coli-derived viral MIP-2 protein, Leu23-Ala93.

      Molecular Weight

      Approximately 8.0 kDa.

      AA Sequence

      LGASWHRPDK CCLGYQKRPL PQVLLSSWYP TSQLCSKPGV IFLTKRGRQV CADKSKDWVK KLMQQLPVTA

      Tag

      None

      Physical Appearance

      Sterile Filtered White lyophilized (freeze-dried) powder.

      Purity

      >97% by SDS-PAGE and HPLC analyses.

      Biological Activity

      The specific activity is determined by the inhibitory effect on monocyte migration response to human MIP-1 alpha using a concentration range of 1.0 µg-10.0 µg/mL of viral MIP-2 will inhibit 25ng/mL of human MIP-1 alpha. Fully biologically active when compared to standard.

      Endotoxin

      < 1.0 EU per 1μg of the protein by the LAL method.

      Formulation

      Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.4, 150mM NaCl.

      Reconstitution

      We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20. Further dilutions should be made in appropriate buffered solutions.

       

      Shipping and Storage

      The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

      Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

       

      Cautions

       

      1. Avoid repeated freeze-thaw cycles.

      2. For your safety and health, please wear lab coats and disposable gloves for operation.

      3. For research use only!

       

      HB220429

      400-6111-883